In the current study, the three monocyte subpopulations: classical (CD14+ CD16+ SLAN−), intermediate (CD14dim CD16+ SLAN−) and non-classical (CD14low/− CD16+ SLAN+) in glioma patients’ peripheral blood were analysed with flow cytometry. This evidence concerns the gene CD14 and central nervous system cancer.